회사 소개
- 법인명: NAGASE Europa GmbH
- 등록 국가: Germany
- 주소: Immermannstr.65c
- 직원 수: 50 - 99
설명:
Established in 1832. Net sales of US$8billion. Highly technically oriented manufacturer. Production of oncology injection, sterile dosage, spray-drying technology, Intermediate, API and excipient. Nagase Medicals, a sterile dosage manufacturer,?completed a new building dedicated for oncology injection and liposomal dosage. Hayashibara, joined Nagase group in February 2012, is only one manufacturer of Trehalose and Pullulan in the world.
사업 활동
원료의약품(API)
제조업체
계약 및 아웃소싱 서비스
유통업체
제약용 화학물질
유통업체
바이오의약품
유통업체
오리지널 원료의약품
유통업체
판매 시장
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan
당사 제품 & 서비스
인증
증거
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기